Table 1 Patient characteristics

n (Male/Female)

457 (182/275)

52 (21/31)

405 (161/244)

0.953

Age (years)

67 ± 13

63 ± 12

68 ± 13

<0.01

Body mass index (Kg/m²)

22 ± 4

21 ± 3

23 ± 4

<0.05

Current smoker, n (%)

110 (24)

13 (25)

97 (24)

0.720

Systolic BP (mmHg)

158 ± 8

157 ± 10

158 ± 8

0.853

Diastolic BP x(mmHg)

92 ± 9

91 ± 9

92 ± 10

0.772

Pulse rate (mmHg)

68 ± 10

70 ± 11

68 ± 10

0.129

Cornell voltage (mm)

15 ± 5

12 ± 6

16 ± 5

<0.001

Diabetes mellitus, n (%)

174 (38)

18 (35)

156 (39)

<0.05

FBG (mg/dl)

113 ± 24

100 ± 20

118 ± 24

<0.05

IRI (μg/ml)

7.3 ± 4.4

7.1 ± 4.8

7.3 ± 4.4

0.062

HOMA-IR

2.1 ± 1.4

2.0 ± 1.3

2.2 ± 1.4

0.053

Dyslipidemia, n (%)

256 (56)

26 (50)

230 (57)

0.286

Total cholesterol (mg/dl)

221 ± 42

218 ± 40

221 ± 41

0.341

LDL cholesterol (mg/dl)

142 ± 37

140 ± 39

142 ± 38

0.358

Triglyceride (mg/dl)

148 ± 70

146 ± 83

149 ± 69

0.279

HDL cholesterol (mg/dl)

49 ± 16

49 ± 15

49 ± 16

0.820

eGFR (ml/min/1.73m²)

64 ± 21

69 ± 21

63 ± 18

<0.05

Log-BNP (pg/ml)

1.8 ± 0.4

1.6 ± 0.4

1.8 ± 0.4

<0.01

d-ROMs test (U. Carr)

333 ± 102

297 ± 107

338 ± 101

<0.001

CAVI

8.9 ± 1.4

8.4 ± 1.2

9.0 ± 1.4

<0.001

Skin AF

2.6 ± 0.5

2.2 ± 0.5

2.6 ± 0.5

<0.001

Log-hs-cTnT (ng/ml)

−1.9 ± 0.3

–

−1.9 ± 0.3

–

 CCB, n (%)

338 (74)

38 (73)

300 (75)

0.712

 RAS inhibitor, n (%)

229 (50)

25 (48)

207 (51)

0.653

 Statin, n (%)

183 (40)

20 (38)

163 (41)

0.699